Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PTH,Parathyroid hormone,Inverse variance weighted,10,1.12 [1.06-1.18],2.48164612895367e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,10,0.92 [0.88-0.96],6.07928872609105e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,10,0.93 [0.89-0.97],0.000248333187327647,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,10,0.94 [0.9-0.97],0.000673352614379974,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,BAMBI,BMP and activin membrane-bound inhibitor homolog,Inverse variance weighted,10,1.07 [1.03-1.12],0.000780488200176136,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,HNMT,Histamine N-methyltransferase,Inverse variance weighted,10,0.94 [0.9-0.98],0.00129150844359576,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CDH15,Cadherin-15,Inverse variance weighted,10,1.07 [1.03-1.12],0.00222508047856559,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FSTL3,Follistatin-related protein 3,Inverse variance weighted,10,0.94 [0.9-0.98],0.00275627923490598,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CDHR1,Cadherin-related family member 1,Inverse variance weighted,10,1.18 [1.06-1.32],0.002842674373475,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,VWC2,Brorin,Inverse variance weighted,10,0.94 [0.9-0.98],0.0032276244932422,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD300C,CMRF35-like molecule 6,Inverse variance weighted,10,0.95 [0.91-0.98],0.00452386988262015,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SNCG,Gamma-synuclein,Inverse variance weighted,10,0.95 [0.92-0.98],0.00478567567409317,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RETN,Resistin,Inverse variance weighted,10,0.95 [0.91-0.98],0.00606017986061094,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SPINK2,Serine protease inhibitor Kazal-type 2,Inverse variance weighted,10,0.95 [0.92-0.99],0.00643579207659101,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CTSL,Cathepsin L1,Inverse variance weighted,10,0.94 [0.9-0.98],0.0072678974557208,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,KLK6,Kallikrein-6,Inverse variance weighted,10,0.93 [0.88-0.98],0.00980091925921185,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,10,0.95 [0.91-0.99],0.00994640923099242,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CX3CL1,Fractalkine,Inverse variance weighted,10,0.95 [0.91-0.99],0.0100706255615421,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,OGN,Mimecan,Inverse variance weighted,10,0.94 [0.9-0.99],0.0115470498152579,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PCDH12,Protocadherin-12,Inverse variance weighted,10,1.18 [1.04-1.34],0.0120191521210179,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,10,0.96 [0.94-0.99],0.0130265124511265,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,10,0.95 [0.91-0.99],0.0130322971314594,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,10,0.95 [0.91-0.99],0.013863055463463,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MFAP5,Microfibrillar-associated protein 5,Inverse variance weighted,10,0.93 [0.88-0.99],0.014005952324203,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,10,0.96 [0.93-0.99],0.0147881288223003,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SERPINB8,Serpin B8,Inverse variance weighted,10,0.96 [0.93-0.99],0.014826603656172,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,10,0.94 [0.9-0.99],0.0149691778410893,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,10,0.95 [0.91-0.99],0.0156804455527463,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FBLN2,Fibulin-2,Inverse variance weighted,10,0.95 [0.91-0.99],0.0166066225193479,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD300A,CMRF35-like molecule 8,Inverse variance weighted,10,0.95 [0.92-0.99],0.0173461227946603,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,10,0.93 [0.87-0.99],0.017641993491897,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CCN3,CCN family member 3,Inverse variance weighted,10,0.94 [0.89-0.99],0.0184357194939786,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,10,0.94 [0.89-0.99],0.0193803959863226,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,10,0.95 [0.91-0.99],0.0198304908415024,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,10,0.96 [0.92-0.99],0.0199216045177127,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CHAD,Chondroadherin,Inverse variance weighted,10,1.06 [1.01-1.11],0.0200893604554306,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,10,0.95 [0.91-0.99],0.0201171932051206,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,10,0.95 [0.92-0.99],0.0203666671321645,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,10,0.93 [0.88-0.99],0.0206147802431881,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,10,0.95 [0.91-0.99],0.0215848654178368,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PGF,Placenta growth factor,Inverse variance weighted,10,0.95 [0.9-0.99],0.0225591069109983,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SPON2,Spondin-2,Inverse variance weighted,10,0.95 [0.91-0.99],0.0245240001276627,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,F3,Tissue factor,Inverse variance weighted,10,0.96 [0.92-0.99],0.0264917258702837,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,0.93 [0.88-0.99],0.0269409414472903,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,10,0.96 [0.92-0.99],0.0269471291652211,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,10,0.94 [0.89-0.99],0.0276459430229513,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CTSV,Cathepsin L2,Inverse variance weighted,10,0.96 [0.92-1],0.0305588272665169,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LGALS3,Galectin-3,Inverse variance weighted,10,0.96 [0.93-1],0.0306308817141644,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Inverse variance weighted,10,0.96 [0.92-1],0.0308750306522244,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,0.96 [0.92-1],0.0312231942680011,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,10,0.96 [0.92-1],0.0320056859763012,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD93,Complement component C1q receptor,Inverse variance weighted,10,0.95 [0.92-1],0.0321818749241218,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,B2M,Beta-2-microglobulin,Inverse variance weighted,10,0.96 [0.92-1],0.0326187651555149,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SBSN,Suprabasin,Inverse variance weighted,10,0.96 [0.92-1],0.0328156382929979,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DKK3,Dickkopf-related protein 3,Inverse variance weighted,10,0.96 [0.92-1],0.0330527066148006,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,Inverse variance weighted,10,0.95 [0.9-1],0.0337545359908081,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,10,0.96 [0.92-1],0.0364534963275655,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,10,0.96 [0.92-1],0.0370432294870845,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PALM2,Paralemmin-2,Inverse variance weighted,10,0.96 [0.92-1],0.037389631022607,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,10,0.96 [0.92-1],0.037528780920833,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,10,0.96 [0.93-1],0.0378452702216206,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,10,1.06 [1-1.11],0.0380236012847157,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,10,0.96 [0.92-1],0.0381991363485698,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,0.96 [0.92-1],0.0389154350222392,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,10,0.95 [0.91-1],0.0396718254638488,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,10,0.95 [0.91-1],0.0401606892539209,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CCN4,CCN family member 4,Inverse variance weighted,10,0.96 [0.92-1],0.0403611325922688,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,10,1.04 [1-1.08],0.0405271546638392,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,10,0.96 [0.92-1],0.0405351821161288,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LMNB2,Lamin-B2,Inverse variance weighted,10,0.95 [0.9-1],0.0410956053860643,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,10,0.96 [0.92-1],0.0413410534380893,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,10,0.96 [0.93-1],0.0443623163527075,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CFC1,Cryptic protein,Inverse variance weighted,10,1.05 [1-1.1],0.0447995173248697,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,10,0.96 [0.92-1],0.0454064508500224,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CA9,Carbonic anhydrase 9,Inverse variance weighted,10,1.04 [1-1.09],0.0460617439631644,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DPT,Dermatopontin,Inverse variance weighted,10,0.96 [0.93-1],0.0467417033817813,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CA14,Carbonic anhydrase 14,Inverse variance weighted,10,1.04 [1-1.08],0.0480331702088176,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CDH3,Cadherin-3,Inverse variance weighted,10,0.95 [0.9-1],0.0485262586275384,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,10,0.96 [0.93-1],0.049264060843674,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,10,0.96 [0.92-1],0.0506088077460934,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,KLK4,Kallikrein-4,Inverse variance weighted,10,0.97 [0.94-1],0.0512843760617046,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,10,0.96 [0.92-1],0.0517555514883981,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MEPE,Matrix extracellular phosphoglycoprotein,Inverse variance weighted,10,1.04 [1-1.09],0.0526601372019545,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD55,Complement decay-accelerating factor,Inverse variance weighted,10,0.96 [0.92-1],0.052741282479312,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,10,0.96 [0.93-1],0.0531809022540213,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PCDHB15,Protocadherin beta-15,Inverse variance weighted,10,1.06 [1-1.13],0.0579334597649533,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,10,0.96 [0.92-1],0.0580345448421541,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,10,0.95 [0.9-1],0.059243607608383,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RGMA,Repulsive guidance molecule A,Inverse variance weighted,10,1.04 [1-1.08],0.0596568628850677,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,GM2A,Ganglioside GM2 activator,Inverse variance weighted,10,0.97 [0.93-1],0.0611749153220322,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",Inverse variance weighted,10,0.95 [0.9-1],0.0617773895065851,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,10,0.96 [0.93-1],0.0657767338654067,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,Inverse variance weighted,10,1.05 [1-1.11],0.066851715785917,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,10,0.94 [0.88-1],0.0671501055515292,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,10,0.96 [0.93-1],0.0674340265624272,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,10,1.04 [1-1.09],0.0674489747577597,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,10,0.96 [0.92-1],0.0690893162087164,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,10,0.96 [0.91-1],0.0691305184467028,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CCN5,CCN family member 5,Inverse variance weighted,10,0.96 [0.91-1],0.0696307389758945,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CHRDL1,Chordin-like protein 1,Inverse variance weighted,10,0.95 [0.9-1],0.0720992608791823,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CFD,Complement factor D,Inverse variance weighted,10,0.95 [0.9-1],0.0734695026063304,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,10,0.96 [0.92-1],0.0754444439634512,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,0.95 [0.91-1.01],0.0780704385872727,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CST6,Cystatin-M,Inverse variance weighted,10,0.94 [0.89-1.01],0.081950364079301,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,10,0.96 [0.91-1.01],0.0867108545050203,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DLK1,Protein delta homolog 1,Inverse variance weighted,10,0.97 [0.93-1],0.0882709813412196,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,OMD,Osteomodulin,Inverse variance weighted,10,1.05 [0.99-1.1],0.0905557577895827,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,AMBP,Protein AMBP,Inverse variance weighted,10,0.96 [0.92-1.01],0.0907299659878156,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,10,0.97 [0.93-1.01],0.0925873864860279,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DMP1,Dentin matrix acidic phosphoprotein 1,Inverse variance weighted,10,1.05 [0.99-1.12],0.093366285400613,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CA12,Carbonic anhydrase 12,Inverse variance weighted,10,0.96 [0.91-1.01],0.0969428980007236,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CDH1,Cadherin-1,Inverse variance weighted,10,0.96 [0.92-1.01],0.100284275824315,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PPL,Periplakin,Inverse variance weighted,10,1.05 [0.99-1.11],0.100369471156698,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DLL1,Delta-like protein 1,Inverse variance weighted,10,0.97 [0.93-1.01],0.102746959100976,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,Inverse variance weighted,10,1.03 [0.99-1.07],0.10304548508234,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DKK4,Dickkopf-related protein 4,Inverse variance weighted,10,1.04 [0.99-1.09],0.104460045871846,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,JAM2,Junctional adhesion molecule B,Inverse variance weighted,10,0.96 [0.92-1.01],0.105960274043856,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,10,0.96 [0.92-1.01],0.106140270857654,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,VEGFB,Vascular endothelial growth factor B,Inverse variance weighted,10,0.97 [0.93-1.01],0.106569885052715,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,10,0.97 [0.93-1.01],0.109343048923606,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TREML2,Trem-like transcript 2 protein,Inverse variance weighted,10,0.97 [0.93-1.01],0.109593274858453,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,0.97 [0.93-1.01],0.110860895662192,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD300E,CMRF35-like molecule 2,Inverse variance weighted,10,0.97 [0.93-1.01],0.111026769329635,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CST3,Cystatin-C,Inverse variance weighted,10,0.96 [0.92-1.01],0.112863448790715,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,10,0.96 [0.91-1.01],0.117971988869351,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,10,0.96 [0.91-1.01],0.119301082466003,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD83,CD83 antigen,Inverse variance weighted,10,0.96 [0.9-1.01],0.119422189626897,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,10,0.95 [0.89-1.01],0.12123948860768,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PCDH17,Protocadherin-17,Inverse variance weighted,10,1.03 [0.99-1.08],0.122274214100251,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FABP4,"Fatty acid-binding protein, adipocyte",Inverse variance weighted,10,0.97 [0.93-1.01],0.122435954242943,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SHISA5,Protein shisa-5,Inverse variance weighted,10,0.97 [0.93-1.01],0.124442553092628,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,10,0.97 [0.92-1.01],0.124613914370302,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ULBP2,UL16-binding protein 2,Inverse variance weighted,10,0.96 [0.91-1.01],0.126345825877688,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,0.97 [0.93-1.01],0.126536536618454,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,AREG,Amphiregulin,Inverse variance weighted,10,0.97 [0.92-1.01],0.129106577670853,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MOG,Myelin-oligodendrocyte glycoprotein,Inverse variance weighted,10,0.97 [0.93-1.01],0.1314951230929,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CLMP,CXADR-like membrane protein,Inverse variance weighted,10,0.97 [0.92-1.01],0.132160035013036,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IL15,Interleukin-15,Inverse variance weighted,10,0.97 [0.93-1.01],0.132950227577503,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,10,0.96 [0.91-1.01],0.132990846134627,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SPP1,Osteopontin,Inverse variance weighted,10,1.04 [0.99-1.09],0.133421939878527,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RNASE6,Ribonuclease K6,Inverse variance weighted,10,0.96 [0.92-1.01],0.133978575549312,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,10,0.97 [0.94-1.01],0.134866493849779,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CCL11,Eotaxin,Inverse variance weighted,10,1.04 [0.99-1.09],0.136339949199941,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD302,CD302 antigen,Inverse variance weighted,10,0.95 [0.88-1.02],0.136992081865413,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,POF1B,Protein POF1B,Inverse variance weighted,10,1.03 [0.99-1.08],0.141778868468434,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PTPRS,Receptor-type tyrosine-protein phosphatase S,Inverse variance weighted,10,0.97 [0.93-1.01],0.142796978230732,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CLEC4G,C-type lectin domain family 4 member G,Inverse variance weighted,10,0.97 [0.93-1.01],0.147926069316523,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CDSN,Corneodesmosin,Inverse variance weighted,10,0.95 [0.89-1.02],0.148457717122725,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,10,0.97 [0.92-1.01],0.150598270232746,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,10,0.97 [0.93-1.01],0.151122856450921,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,10,0.97 [0.93-1.01],0.151501658209282,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,10,0.97 [0.93-1.01],0.153139374118628,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CDH6,Cadherin-6,Inverse variance weighted,10,1.03 [0.99-1.07],0.153194495427744,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,10,0.97 [0.93-1.01],0.154063992550759,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,10,0.95 [0.88-1.02],0.15458071205304,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ALCAM,CD166 antigen,Inverse variance weighted,10,0.97 [0.94-1.01],0.157594868338405,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,COLEC12,Collectin-12,Inverse variance weighted,10,0.97 [0.94-1.01],0.158367330212716,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,0.97 [0.93-1.01],0.159024430182383,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SDC1,Syndecan-1,Inverse variance weighted,10,0.97 [0.92-1.01],0.160025457671506,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,BGLAP,Osteocalcin,Inverse variance weighted,10,1.04 [0.98-1.1],0.162500283809491,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,JAM3,Junctional adhesion molecule C,Inverse variance weighted,10,1.04 [0.98-1.1],0.163525399165048,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,10,0.97 [0.93-1.01],0.163704071705483,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,BSG,Basigin,Inverse variance weighted,10,0.97 [0.93-1.01],0.165631921655441,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,10,0.97 [0.93-1.01],0.166223587890144,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PALM,Paralemmin-1,Inverse variance weighted,10,0.97 [0.93-1.01],0.176051131379835,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,10,1.03 [0.99-1.07],0.176855663273427,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TGFA,Protransforming growth factor alpha,Inverse variance weighted,10,0.96 [0.9-1.02],0.179834738893755,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ENDOU,Poly(U)-specific endoribonuclease,Inverse variance weighted,10,0.97 [0.92-1.02],0.180717473195303,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,10,0.98 [0.94-1.01],0.181998529884363,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,10,0.97 [0.93-1.01],0.182915421764683,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,10,0.96 [0.91-1.02],0.184442577929257,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,10,1.02 [0.99-1.06],0.186716329912952,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,Inverse variance weighted,10,1.03 [0.99-1.07],0.187598400284262,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,BTN2A1,Butyrophilin subfamily 2 member A1,Inverse variance weighted,10,0.97 [0.92-1.02],0.191142474849343,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LGALS9,Galectin-9,Inverse variance weighted,10,0.98 [0.94-1.01],0.191802061380564,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,10,0.97 [0.92-1.02],0.201474670862397,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,10,0.97 [0.93-1.01],0.202132119215936,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,10,0.97 [0.93-1.02],0.203206706232174,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,10,0.98 [0.94-1.01],0.20436017304379,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,10,1.03 [0.99-1.07],0.205767273287354,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FLT1,Vascular endothelial growth factor receptor 1,Inverse variance weighted,10,0.97 [0.93-1.02],0.208379843822166,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,10,0.98 [0.94-1.01],0.210358031571278,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,EFNA1,Ephrin-A1,Inverse variance weighted,10,0.97 [0.92-1.02],0.210424001991714,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,10,0.97 [0.94-1.02],0.213744703570444,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PI3,Elafin,Inverse variance weighted,10,0.96 [0.9-1.03],0.214295261823198,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,10,0.98 [0.94-1.01],0.216801913559986,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,10,0.97 [0.93-1.02],0.222580182970517,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NECTIN4,Nectin-4,Inverse variance weighted,10,0.96 [0.9-1.02],0.225636831070512,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,10,0.98 [0.95-1.01],0.229447988789948,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,GRN,Progranulin,Inverse variance weighted,10,0.97 [0.93-1.02],0.231213532933153,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,APOH,Beta-2-glycoprotein 1,Inverse variance weighted,10,0.98 [0.94-1.01],0.231472461954291,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TFF1,Trefoil factor 1,Inverse variance weighted,10,0.97 [0.92-1.02],0.235408347077075,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,0.97 [0.91-1.02],0.236862541845957,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,10,1.02 [0.98-1.06],0.237505526787271,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,COL1A1,Collagen alpha-1(I) chain,Inverse variance weighted,10,1.02 [0.98-1.07],0.237754441321247,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,10,0.96 [0.91-1.02],0.241724682014529,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,10,0.98 [0.94-1.02],0.242606396681228,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,XG,Glycoprotein Xg,Inverse variance weighted,10,0.98 [0.95-1.01],0.243533880509523,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,0.97 [0.92-1.02],0.250748610858861,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Inverse variance weighted,10,0.97 [0.91-1.02],0.253332271735418,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RBP7,Retinoid-binding protein 7,Inverse variance weighted,10,0.98 [0.94-1.02],0.255495469627468,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,0.97 [0.93-1.02],0.255544951338769,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MMP10,Stromelysin-2,Inverse variance weighted,10,0.98 [0.94-1.02],0.25639369800316,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,10,0.97 [0.93-1.02],0.258473590669389,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,10,0.97 [0.93-1.02],0.263197647169057,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ADM,Pro-adrenomedullin,Inverse variance weighted,10,0.97 [0.92-1.02],0.266261450664338,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,VASN,Vasorin,Inverse variance weighted,10,0.98 [0.93-1.02],0.268509545029815,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RSPO3,R-spondin-3,Inverse variance weighted,10,0.97 [0.92-1.02],0.268623049063999,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,10,0.98 [0.94-1.02],0.273011569381835,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,10,0.97 [0.91-1.03],0.273082135651133,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,APOA2,Apolipoprotein A-II,Inverse variance weighted,10,0.98 [0.94-1.02],0.274603958849897,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NPPC,C-type natriuretic peptide,Inverse variance weighted,10,0.97 [0.92-1.02],0.275567316762894,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,10,0.98 [0.94-1.02],0.281600198745573,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CA4,Carbonic anhydrase 4,Inverse variance weighted,10,0.98 [0.94-1.02],0.286930609761093,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,KLRF1,Killer cell lectin-like receptor subfamily F member 1,Inverse variance weighted,10,1.02 [0.98-1.06],0.288592452373765,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,10,0.98 [0.94-1.02],0.290652907112215,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,10,0.98 [0.94-1.02],0.293259886089414,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,0.98 [0.94-1.02],0.301713620684434,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SCG2,Secretogranin-2,Inverse variance weighted,10,1.03 [0.97-1.1],0.302930774007285,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IL19,Interleukin-19,Inverse variance weighted,10,0.97 [0.93-1.02],0.30347295655837,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,10,0.98 [0.94-1.02],0.30375771284744,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,GFRA3,GDNF family receptor alpha-3,Inverse variance weighted,10,0.97 [0.91-1.03],0.309009792219168,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,10,0.98 [0.93-1.02],0.315072468476955,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,10,0.98 [0.94-1.02],0.316493258745565,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ANGPTL3,Angiopoietin-related protein 3,Inverse variance weighted,10,0.98 [0.94-1.02],0.32039007352764,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,10,0.98 [0.93-1.02],0.323247575535335,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,THBD,Thrombomodulin,Inverse variance weighted,10,0.98 [0.94-1.02],0.3259177752363,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FOLR1,Folate receptor alpha,Inverse variance weighted,10,0.98 [0.94-1.02],0.326379911623097,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CALCA,Calcitonin,Inverse variance weighted,10,0.98 [0.94-1.02],0.329840748360686,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,0.96 [0.9-1.04],0.331040882885204,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,10,0.97 [0.92-1.03],0.334005340282771,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FABP6,Gastrotropin,Inverse variance weighted,10,1.02 [0.98-1.06],0.339654598896894,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CCL3,C-C motif chemokine 3,Inverse variance weighted,10,0.98 [0.94-1.02],0.340999783534922,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,10,1.02 [0.98-1.06],0.341322090903006,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PHLDB1,Pleckstrin homology-like domain family B member 1,Inverse variance weighted,10,1.02 [0.98-1.06],0.345210351784147,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,10,0.98 [0.94-1.02],0.34585116025829,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,EFNA4,Ephrin-A4,Inverse variance weighted,10,0.98 [0.94-1.02],0.351848249847887,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,10,0.98 [0.93-1.03],0.357647116635956,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CCL14,C-C motif chemokine 14,Inverse variance weighted,10,0.98 [0.94-1.02],0.363322821199371,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,10,0.98 [0.95-1.02],0.364460573817171,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PTK7,Inactive tyrosine-protein kinase 7,Inverse variance weighted,10,0.98 [0.92-1.03],0.368292892019525,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,0.98 [0.95-1.02],0.368491701715372,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NXPH3,Neurexophilin-3,Inverse variance weighted,10,1.02 [0.98-1.06],0.36939140624969,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RSPO1,R-spondin-1,Inverse variance weighted,10,0.98 [0.94-1.02],0.370484856051397,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RBP2,Retinol-binding protein 2,Inverse variance weighted,10,0.97 [0.9-1.04],0.371535571426982,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,VGF,Neurosecretory protein VGF,Inverse variance weighted,10,1.02 [0.98-1.06],0.372120113230839,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,10,0.98 [0.94-1.02],0.373905040334013,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,10,0.98 [0.93-1.03],0.375091822231261,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,HIP1R,Huntingtin-interacting protein 1-related protein,Inverse variance weighted,10,0.98 [0.94-1.02],0.379005729268163,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NECTIN2,Nectin-2,Inverse variance weighted,10,0.98 [0.93-1.03],0.379834561515303,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,10,0.98 [0.95-1.02],0.381112456649058,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,10,1.02 [0.98-1.06],0.381553279118934,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,10,0.97 [0.91-1.04],0.382359350785344,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,EDN1,Endothelin-1,Inverse variance weighted,10,0.97 [0.92-1.03],0.386783651700656,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,10,0.98 [0.94-1.02],0.391423670604089,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,GFRA2,GDNF family receptor alpha-2,Inverse variance weighted,10,0.97 [0.91-1.04],0.397610252086395,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,10,0.98 [0.94-1.03],0.401826041205613,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,10,1.02 [0.98-1.06],0.403353383781233,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,10,0.98 [0.94-1.02],0.407006481430922,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,UMOD,Uromodulin,Inverse variance weighted,10,0.99 [0.96-1.02],0.409948738440025,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,10,0.98 [0.92-1.03],0.410240306229047,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Inverse variance weighted,10,0.98 [0.94-1.02],0.415367562302163,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DSG3,Desmoglein-3,Inverse variance weighted,10,0.98 [0.93-1.03],0.419498153958653,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PSAP,Prosaposin,Inverse variance weighted,10,0.98 [0.94-1.03],0.421454574703398,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SEPTIN8,Septin-8,Inverse variance weighted,10,1.02 [0.98-1.06],0.423304665909127,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ZBTB17,Zinc finger and BTB domain-containing protein 17,Inverse variance weighted,10,0.98 [0.94-1.03],0.426991465512557,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,STC1,Stanniocalcin-1,Inverse variance weighted,10,0.98 [0.94-1.02],0.42708107059684,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,OCLN,Occludin,Inverse variance weighted,10,0.98 [0.94-1.03],0.427330434755522,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,10,0.98 [0.95-1.02],0.42960030033611,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,10,1.03 [0.96-1.11],0.433223524393078,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,10,0.98 [0.94-1.03],0.434795871239804,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,INHBB,Inhibin beta B chain,Inverse variance weighted,10,0.98 [0.94-1.03],0.440289808259836,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SCN4B,Sodium channel subunit beta-4,Inverse variance weighted,10,0.98 [0.94-1.03],0.447924417586867,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,10,0.98 [0.94-1.03],0.448063140621817,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SPINK6,Serine protease inhibitor Kazal-type 6,Inverse variance weighted,10,1.02 [0.98-1.06],0.449624441968857,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,AGRP,Agouti-related protein,Inverse variance weighted,10,1.02 [0.97-1.07],0.450446598337198,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,10,0.98 [0.92-1.04],0.452689908210058,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,10,0.98 [0.94-1.03],0.456461665493011,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,VIT,Vitrin,Inverse variance weighted,10,1.01 [0.98-1.05],0.458038779855127,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,10,0.99 [0.95-1.02],0.461881182351963,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,APOA4,Apolipoprotein A-IV,Inverse variance weighted,10,0.98 [0.94-1.03],0.463402409991245,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,Inverse variance weighted,10,1.02 [0.97-1.06],0.471199615420957,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,10,0.99 [0.95-1.02],0.472803599189611,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Inverse variance weighted,10,0.98 [0.92-1.04],0.474145918455661,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,10,0.98 [0.94-1.03],0.478318548211556,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PENK,Proenkephalin-A,Inverse variance weighted,10,1.01 [0.97-1.06],0.481660670648436,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,10,1.02 [0.97-1.06],0.484842827641261,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TFF3,Trefoil factor 3,Inverse variance weighted,10,0.99 [0.95-1.03],0.486039919973042,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,10,0.99 [0.95-1.03],0.487291314082539,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CALB1,Calbindin,Inverse variance weighted,10,0.98 [0.93-1.03],0.488439885936015,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,Inverse variance weighted,10,0.99 [0.95-1.03],0.492491584662927,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IL17C,Interleukin-17C,Inverse variance weighted,10,0.99 [0.95-1.03],0.493645283843149,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TGFBR1,TGF-beta receptor type-1,Inverse variance weighted,10,1.02 [0.97-1.06],0.498168594024473,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ART3,Ecto-ADP-ribosyltransferase 3,Inverse variance weighted,10,0.99 [0.95-1.03],0.501536309619018,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,HSPB6,Heat shock protein beta-6,Inverse variance weighted,10,0.99 [0.95-1.02],0.50173056781042,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FGF21,Fibroblast growth factor 21,Inverse variance weighted,10,0.98 [0.93-1.04],0.502895067744472,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PNLIPRP1,Inactive pancreatic lipase-related protein 1,Inverse variance weighted,10,1.01 [0.97-1.06],0.503005761473047,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PSAPL1,Proactivator polypeptide-like 1,Inverse variance weighted,10,0.98 [0.94-1.03],0.5036821755603,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NUCB2,Nucleobindin-2,Inverse variance weighted,10,1.01 [0.97-1.05],0.505444945043847,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD99,CD99 antigen,Inverse variance weighted,10,1.01 [0.98-1.05],0.508880395582803,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,KLK8,Kallikrein-8,Inverse variance weighted,10,0.98 [0.92-1.04],0.513700292846943,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DTNB,Dystrobrevin beta,Inverse variance weighted,10,1.01 [0.97-1.05],0.523328904483973,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RNASE4,Ribonuclease 4,Inverse variance weighted,10,0.98 [0.94-1.03],0.523941566696161,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FAM3B,Protein FAM3B,Inverse variance weighted,10,0.98 [0.93-1.04],0.527492517828559,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DSC2,Desmocollin-2,Inverse variance weighted,10,0.99 [0.95-1.03],0.532459635246509,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,10,0.99 [0.94-1.03],0.532865903787474,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LCN15,Lipocalin-15,Inverse variance weighted,10,0.98 [0.93-1.04],0.535311624288792,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,REN,Renin,Inverse variance weighted,10,0.99 [0.95-1.03],0.535412958699404,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,GP1BA,Platelet glycoprotein Ib alpha chain,Inverse variance weighted,10,1.02 [0.97-1.07],0.53916601370766,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LAYN,Layilin,Inverse variance weighted,10,0.99 [0.95-1.03],0.540217168469073,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,BCL2L15,Bcl-2-like protein 15,Inverse variance weighted,10,1.01 [0.97-1.06],0.542594861017893,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SYT1,Synaptotagmin-1,Inverse variance weighted,10,0.99 [0.94-1.03],0.544121890854904,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,10,0.99 [0.95-1.03],0.547381774273834,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,KIAA0319,Dyslexia-associated protein KIAA0319,Inverse variance weighted,10,1.01 [0.97-1.05],0.557215712428272,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,10,0.98 [0.94-1.04],0.560016582143291,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,10,1.01 [0.98-1.04],0.56093736003635,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SLC39A14,Zinc transporter ZIP14,Inverse variance weighted,10,1.01 [0.97-1.06],0.563807508686564,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CTRB1,Chymotrypsinogen B,Inverse variance weighted,10,1.01 [0.97-1.05],0.564946640486554,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,10,0.98 [0.92-1.04],0.565807199619884,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MXRA8,Matrix remodeling-associated protein 8,Inverse variance weighted,10,1.01 [0.97-1.05],0.573099507908057,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RTBDN,Retbindin,Inverse variance weighted,10,0.98 [0.93-1.04],0.573407999467425,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,GUCA2A,Guanylin,Inverse variance weighted,10,1.01 [0.97-1.05],0.574613645752166,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,KLK11,Kallikrein-11,Inverse variance weighted,10,0.99 [0.95-1.03],0.576154471731314,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,10,0.99 [0.94-1.03],0.579929909587318,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DCN,Decorin,Inverse variance weighted,10,1.01 [0.97-1.05],0.58024866937381,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SLITRK6,SLIT and NTRK-like protein 6,Inverse variance weighted,10,0.99 [0.95-1.03],0.580300274349449,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,10,0.99 [0.94-1.04],0.582000014134756,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,10,0.98 [0.93-1.04],0.583434872881277,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,10,0.99 [0.95-1.03],0.584216105987696,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,10,0.98 [0.93-1.04],0.586198042317543,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,10,1.01 [0.97-1.06],0.591081611717511,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DSG2,Desmoglein-2,Inverse variance weighted,10,0.99 [0.95-1.03],0.595521181758871,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SEZ6L,Seizure 6-like protein,Inverse variance weighted,10,0.99 [0.95-1.03],0.596804924743233,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LGALS1,Galectin-1,Inverse variance weighted,10,0.99 [0.94-1.04],0.598455011554161,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PODXL2,Podocalyxin-like protein 2,Inverse variance weighted,10,0.99 [0.95-1.03],0.603387147001592,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LGALS4,Galectin-4,Inverse variance weighted,10,1.01 [0.97-1.06],0.604972972076274,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,10,1.01 [0.97-1.05],0.611446440895477,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,10,0.99 [0.95-1.03],0.614496479764545,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,10,0.99 [0.93-1.04],0.61744213828533,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MB,Myoglobin,Inverse variance weighted,10,0.99 [0.96-1.03],0.619808417903388,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,10,0.99 [0.95-1.03],0.620359832413617,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,10,0.99 [0.95-1.03],0.621744654881033,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,10,0.99 [0.95-1.03],0.623267502401629,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,10,0.99 [0.95-1.03],0.625517127207129,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,VCAN,Versican core protein,Inverse variance weighted,10,1.01 [0.97-1.05],0.633462290545525,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NEO1,Neogenin,Inverse variance weighted,10,0.99 [0.95-1.03],0.634075916937483,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FGF23,Fibroblast growth factor 23,Inverse variance weighted,10,1.01 [0.96-1.07],0.634538192237339,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,10,0.99 [0.95-1.03],0.645515577445088,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,10,0.99 [0.95-1.03],0.650235924272316,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CCL16,C-C motif chemokine 16,Inverse variance weighted,10,0.99 [0.96-1.03],0.654607596902697,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PRSS2,Trypsin-2,Inverse variance weighted,10,0.99 [0.94-1.04],0.656200295209977,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,10,0.99 [0.95-1.04],0.660859856481762,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,10,0.99 [0.95-1.04],0.661231529218615,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,10,1.01 [0.97-1.05],0.664571448850136,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RNASET2,Ribonuclease T2,Inverse variance weighted,10,0.99 [0.95-1.03],0.666315246584521,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FAM3C,Protein FAM3C,Inverse variance weighted,10,0.99 [0.93-1.05],0.669570783592154,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,10,0.99 [0.95-1.03],0.669603305318541,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MYBPC1,"Myosin-binding protein C, slow-type",Inverse variance weighted,10,1.01 [0.97-1.05],0.670684127016214,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,0.99 [0.93-1.05],0.671898335256702,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,UNC5D,Netrin receptor UNC5D,Inverse variance weighted,10,1.01 [0.97-1.05],0.673194749062984,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DRAXIN,Draxin,Inverse variance weighted,10,0.99 [0.94-1.04],0.674779864353007,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,AGRN,Agrin,Inverse variance weighted,10,0.99 [0.94-1.04],0.679673243193295,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,10,0.99 [0.95-1.04],0.682454191443646,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD46,Membrane cofactor protein,Inverse variance weighted,10,0.99 [0.95-1.03],0.68250654925783,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD160,CD160 antigen,Inverse variance weighted,10,0.99 [0.95-1.03],0.683189612489559,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,0.99 [0.95-1.04],0.683332583424935,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RGMB,RGM domain family member B,Inverse variance weighted,10,1.01 [0.97-1.05],0.686192544204226,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SIGLEC5,Sialic acid-binding Ig-like lectin 5,Inverse variance weighted,10,0.99 [0.96-1.03],0.686945442311455,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,10,1.01 [0.96-1.06],0.687668715799078,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,KIRREL2,Kin of IRRE-like protein 2,Inverse variance weighted,10,0.99 [0.95-1.03],0.689747249024525,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PTPRR,Receptor-type tyrosine-protein phosphatase R,Inverse variance weighted,10,0.99 [0.95-1.03],0.700422393593351,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MYL3,Myosin light chain 3,Inverse variance weighted,10,0.99 [0.95-1.03],0.700483078126115,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MLN,Promotilin,Inverse variance weighted,10,0.99 [0.94-1.05],0.706625764744421,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,10,0.99 [0.94-1.04],0.712831769329999,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NRP1,Neuropilin-1,Inverse variance weighted,10,0.99 [0.95-1.03],0.722917344645642,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PGA4,Pepsin A-4,Inverse variance weighted,10,0.99 [0.95-1.04],0.724556161335888,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,Inverse variance weighted,10,0.99 [0.95-1.04],0.726015769652594,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,10,0.99 [0.92-1.06],0.737105318141464,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD27,CD27 antigen,Inverse variance weighted,10,1.01 [0.95-1.07],0.739856098418923,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FAM3D,Protein FAM3D,Inverse variance weighted,10,1.01 [0.97-1.04],0.739940256980818,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SPINK5,Serine protease inhibitor Kazal-type 5,Inverse variance weighted,10,0.99 [0.94-1.04],0.743141623032135,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,10,0.99 [0.93-1.05],0.745319710315647,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MMP13,Collagenase 3,Inverse variance weighted,10,1.01 [0.97-1.05],0.74921819241309,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PLA2G1B,Phospholipase A2,Inverse variance weighted,10,1.01 [0.97-1.05],0.750360440438553,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CKB,Creatine kinase B-type,Inverse variance weighted,10,1.01 [0.96-1.06],0.750714209939664,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NEFL,Neurofilament light polypeptide,Inverse variance weighted,10,0.99 [0.96-1.03],0.7561234764157,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,GPC1,Glypican-1,Inverse variance weighted,10,0.99 [0.96-1.03],0.757052008146876,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,10,0.99 [0.96-1.03],0.759294933810083,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SUSD5,Sushi domain-containing protein 5,Inverse variance weighted,10,0.99 [0.96-1.03],0.763912530755785,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PRELP,Prolargin,Inverse variance weighted,10,0.99 [0.96-1.03],0.765048333792382,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,10,0.99 [0.94-1.04],0.77070745523779,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NRP2,Neuropilin-2,Inverse variance weighted,10,1.01 [0.97-1.05],0.781235533613019,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PDIA3,Protein disulfide-isomerase A3,Inverse variance weighted,10,1.01 [0.95-1.07],0.784077098275474,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MMP7,Matrilysin,Inverse variance weighted,10,0.99 [0.93-1.05],0.785161396616662,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,10,1.01 [0.97-1.05],0.788299065255256,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,GPR158,Probable G-protein coupled receptor 158,Inverse variance weighted,10,1.01 [0.96-1.05],0.788642120939909,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,AHNAK,Neuroblast differentiation-associated protein AHNAK,Inverse variance weighted,10,0.99 [0.95-1.04],0.788689747756308,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,1.01 [0.96-1.05],0.797012539355324,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SNRPB2,U2 small nuclear ribonucleoprotein B'',Inverse variance weighted,10,0.99 [0.95-1.04],0.798290382204078,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TMPRSS11D,Transmembrane protease serine 11D,Inverse variance weighted,10,1.01 [0.94-1.08],0.80080876129768,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,10,0.99 [0.93-1.06],0.805327116405862,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,REG1A,Lithostathine-1-alpha,Inverse variance weighted,10,0.99 [0.92-1.07],0.80715508221432,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,10,1.01 [0.96-1.05],0.813294701073587,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,10,1.01 [0.95-1.07],0.814723900313017,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CALB2,Calretinin,Inverse variance weighted,10,1 [0.95-1.04],0.821028948251545,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,REG1B,Lithostathine-1-beta,Inverse variance weighted,10,0.99 [0.92-1.07],0.82156892379644,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,10,0.99 [0.94-1.05],0.82292420057145,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MSMB,Beta-microseminoprotein,Inverse variance weighted,10,1 [0.97-1.03],0.826427428826475,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,DPY30,Protein dpy-30 homolog,Inverse variance weighted,10,1 [0.95-1.04],0.827554172445127,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,10,1.01 [0.96-1.05],0.827878562675612,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,10,1.01 [0.96-1.05],0.828216114160513,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,10,1 [0.96-1.04],0.82877344410261,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SEMA3F,Semaphorin-3F,Inverse variance weighted,10,1 [0.96-1.04],0.843179467017902,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CCL23,C-C motif chemokine 23,Inverse variance weighted,10,1 [0.97-1.04],0.843673771638072,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,10,1 [0.96-1.05],0.846231820491495,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,10,1.01 [0.95-1.06],0.847139890314098,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SPRR3,Small proline-rich protein 3,Inverse variance weighted,10,1 [0.95-1.05],0.850091167163228,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ANG,Angiogenin,Inverse variance weighted,10,1 [0.96-1.03],0.851485504617563,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SEL1L,Protein sel-1 homolog 1,Inverse variance weighted,10,1 [0.96-1.04],0.854389294411507,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,AGER,Advanced glycosylation end product-specific receptor,Inverse variance weighted,10,1 [0.96-1.04],0.858883340930158,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,10,1 [0.95-1.04],0.859473638389424,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SLC39A5,Zinc transporter ZIP5,Inverse variance weighted,10,1 [0.96-1.04],0.859916797800873,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD200,OX-2 membrane glycoprotein,Inverse variance weighted,10,1 [0.96-1.04],0.865835199219521,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,XCL1,Lymphotactin,Inverse variance weighted,10,1 [0.97-1.04],0.866850861696638,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SPARCL1,SPARC-like protein 1,Inverse variance weighted,10,1 [0.97-1.04],0.867342347079998,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,10,1 [0.95-1.05],0.870029314771489,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,10,1 [0.95-1.04],0.875541813326671,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RBP5,Retinol-binding protein 5,Inverse variance weighted,10,1 [0.95-1.04],0.875624293899619,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,S100G,Protein S100-G,Inverse variance weighted,10,1 [0.94-1.05],0.878776110027708,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PRSS8,Prostasin,Inverse variance weighted,10,1 [0.96-1.04],0.889333859591521,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,RTN4R,Reticulon-4 receptor,Inverse variance weighted,10,1 [0.96-1.04],0.890053031872976,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,10,1 [0.96-1.04],0.891843970405856,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD59,CD59 glycoprotein,Inverse variance weighted,10,1 [0.96-1.04],0.898241816634185,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,1 [0.96-1.04],0.899027643205576,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CCL27,C-C motif chemokine 27,Inverse variance weighted,10,1 [0.95-1.05],0.899397002450556,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,10,1 [0.96-1.04],0.900253474299831,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,KITLG,Kit ligand,Inverse variance weighted,10,1 [0.96-1.04],0.900451792076164,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CHGB,Secretogranin-1,Inverse variance weighted,10,1 [0.97-1.04],0.901753900789106,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,10,1 [0.96-1.04],0.903738006298364,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,MMP3,Stromelysin-1,Inverse variance weighted,10,1 [0.96-1.04],0.905616954624577,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SEMA3G,Semaphorin-3G,Inverse variance weighted,10,1 [0.96-1.04],0.906725188441546,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CHGA,Chromogranin-A,Inverse variance weighted,10,1 [0.96-1.04],0.910688442702142,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,10,1 [0.96-1.04],0.918207275510549,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FGF5,Fibroblast growth factor 5,Inverse variance weighted,10,1 [0.96-1.04],0.918254681929825,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,10,1 [0.97-1.03],0.92131157672913,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IMMT,MICOS complex subunit MIC60,Inverse variance weighted,10,1 [0.95-1.06],0.921471056151759,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,10,1 [0.96-1.05],0.930551601335096,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,10,1 [0.95-1.05],0.931196447204935,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD7,T-cell antigen CD7,Inverse variance weighted,10,1 [0.95-1.05],0.933302840249303,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CCL15,C-C motif chemokine 15,Inverse variance weighted,10,1 [0.97-1.04],0.933474230012319,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,10,1 [0.96-1.04],0.934129240942296,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ANXA5,Annexin A5,Inverse variance weighted,10,1 [0.96-1.05],0.934238311706264,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,10,1 [0.96-1.04],0.942761255429812,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Inverse variance weighted,10,1 [0.96-1.04],0.946765193103921,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,10,1 [0.96-1.04],0.950330572461891,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,TFF2,Trefoil factor 2,Inverse variance weighted,10,1 [0.94-1.06],0.952047107643582,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,WNT9A,Protein Wnt-9a,Inverse variance weighted,10,1 [0.96-1.04],0.954911372071938,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,10,1 [0.96-1.04],0.957440997572858,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,10,1 [0.94-1.07],0.959564474851477,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CTSZ,Cathepsin Z,Inverse variance weighted,10,1 [0.96-1.04],0.960949439685226,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SPON1,Spondin-1,Inverse variance weighted,10,1 [0.95-1.05],0.970639874797518,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,10,1 [0.96-1.04],0.971859350265257,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Inverse variance weighted,10,1 [0.92-1.09],0.976180670931892,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,SCGB1A1,Uteroglobin,Inverse variance weighted,10,1 [0.96-1.04],0.979402612689908,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,ACTA2,"Actin, aortic smooth muscle",Inverse variance weighted,10,1 [0.96-1.04],0.982404288520301,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CYTL1,Cytokine-like protein 1,Inverse variance weighted,10,1 [0.96-1.04],0.984149700229454,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,10,1 [0.96-1.04],0.98856848288641,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CSTB,Cystatin-B,Inverse variance weighted,10,1 [0.96-1.04],0.995393915244845,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,10,1 [0.97-1.03],0.997619795876282,trans
